Home›Companies›Biotech & Pharma›Cellphire

Cellphire, Inc.

Updated Oct 29, 2026·Latest SEC filing Dec 11, 2025·Suggest an edit

About Cellphire

Cellphire is a private company based in Rockville, Maryland. It has reported $5,000,000 raised in two offerings on Form D since October 2023. Its chief executive is Michael Gaffney.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 26, 2025Dec 11, 2025$3,000,000fully sold19$157KDebtRule 506(b)Form D ↗
Sep 19, 2023Oct 3, 2023$2,000,000of $8.0M target1$2.0MDebtRule 506(b)Form D ↗
Total, two offerings$5,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cellphire's Form D filed Dec 11, 2025.

PC
RJ
Rafael Jorda
Director
TD
Thomas Dubin
Director
MG
Michael Gaffney
Chief Executive Officer and director
DW
Derek Woods
Director
Randall Stanicky
Randall Stanicky
Director
Also a chief financial officer at Click Therapeutics.
JP
James Peake
Director

Earlier filings also listed Rob Woods (executive officer, last listed Oct 2023), David Hirsh (director, last listed Oct 2023), Cristiane Wolfe (executive officer, last listed Oct 2023) and Angela Howerton (executive officer, last listed Oct 2023).

Sources

  1. SECCellphire, Inc. filing history